Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update

Exposure-Response of Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients

(2016) Jian Wang et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study

(2016) Gábor Kovács et al.   LANCET ONCOLOGY

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial

(2015) Hyoung Jin Kang et al.   LANCET ONCOLOGY

Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial

(2015) Sameer Bakhshi et al.   SUPPORTIVE CARE IN CANCER

Randomized Pharmacokinetic Study Comparing Subcutaneous and Intravenous Palonosetron in Cancer Patients Treated with Platinum Based Chemotherapy

(2014) Belen Sadaba et al.   PLoS One

Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy

(2014) Yosuke Ikari et al.   SUPPORTIVE CARE IN CANCER

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

(2014) Marko Popovic et al.   SUPPORTIVE CARE IN CANCER

Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trial

(2014) Tulla Spinelli et al.   SpringerPlus

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

(2013) Jeffrey C. Andrews et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: A prospective, observational study

(2013) Megan Bodge et al.   PEDIATRIC BLOOD & CANCER

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients

(2013) L. Lee Dupuis et al.   PEDIATRIC BLOOD & CANCER

Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives

(2013) Selma Calcagnile et al.   SUPPORTIVE CARE IN CANCER

Emesis control by aprepitant in children and adolescents with chemotherapy

(2013) Tiene G. M. Bauters et al.   International Journal of Clinical Pharmacy

Liquid chromatography–electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of palonosetron in human plasma and urine: Application to a pharmacokinetic study

(2012) Pengfei Li et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate

(2012) Sambavy Nadaraja et al.   PEDIATRIC BLOOD & CANCER

Determination of palonosetron in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study

(2011) Shuyan Yang et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients

(2011) L. Lee Dupuis et al.   PEDIATRIC BLOOD & CANCER

Palonosetron to prevent nausea and vomiting in children undergoing BMT: efficacy and safety

(2010) M Ripaldi et al.   BONE MARROW TRANSPLANTATION

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

(2009) M. Maemondo et al.   ANNALS OF ONCOLOGY

Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children

(2008) Ana Carolina Sepúlveda-Vildósola et al.   ARCHIVES OF MEDICAL RESEARCH

Sensitive and Selective LC-MS-MS Assay for the Quantification of Palonosetron in Human Plasma and Its Application to a Pharmacokinetic Study

(2008) Wen Zhang et al.   CHROMATOGRAPHIA

Going from evidence to recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal